About Elmed Probiotics
Elmed Probiotics is a company based in Hyderabad (India). Elmed Probiotics has raised $2.7 million across 1 funding round from investors including NABVENTURES. The company has 26 employees. Elmed Probiotics offers products and services including Probiotics for Human Health and Probiotics for Animal and Agriculture Health.
- Headquarter Hyderabad, India
- Employees 26
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook Instagram
- Legal Name Elmed Life Sciences Private Limited
- Date of Incorporation 13 Dec, 2018
- Jurisdiction Medchal Malkajgiri, Telangana, India
- Annual Revenue₹16.97 Cr
FY 2025 · +48% YoY
- Net Profit₹2.08 Cr
FY 2025 · 12% margin
- EBITDA₹4.00 Cr
FY 2025 · 24% margin
- Total Equity Funding$2.7M (USD)
in 1 rounds
- Latest Funding Round$2.7M (USD), Seed
Mar 2026
- Investors
- Employee Count26
Associated legal entities of Elmed Probiotics
Elmed Probiotics operates through Elmed Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elmed Life Sciences Private Limited CIN U24230TG2018PTC129033 | Active | 13 Dec 2018 | Medchal Malkajgiri, Telangana | ₹17.0 Cr | 26 | 2 | View details |
Products & Services of Elmed Probiotics
Elmed Probiotics offers a comprehensive portfolio of products and services, including Probiotics for Human Health and Probiotics for Animal and Agriculture Health.
Probiotics are manufactured for gut and skin health through various forms like vials, capsules, and syrups
Probiotics are provided for animal health sectors including poultry and cattle, as well as for soil and water management in agriculture
Funding Insights of Elmed Probiotics
Elmed Probiotics has successfully raised a total of $2.7M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.7 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.7M
- Total Rounds 1
- Last Round Seed — $2.7M
- First Round $2.7M
(Mar 2026)
- Investors Count 1
All 1 funding rounds of Elmed Probiotics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2026 | $2.7M | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Elmed Probiotics
Elmed Probiotics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NABVENTURES.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | nabventures.in | - |
Investor details for Elmed Probiotics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Elmed Life Sciences Private Limited (Elmed Probiotics)
Elmed Life Sciences Private Limited is the primary company behind Elmed Probiotics. The board of Elmed Life Sciences Private Limited currently have 2 directors; the longest-serving is Pruthivin Reddy Madduri, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pruthivin Reddy Madduri DIN 08304067 | Managing Director | 13 Dec 2018 | 7 yrs 9 mo | Elmed Life Sciences Private Limited |
| Nikhil Konkathi DIN 08304068 | Director | 13 Dec 2018 | 7 yrs 9 mo | Elmed Life Sciences Private Limited |
People of Elmed Probiotics
6 people are tracked at Elmed Probiotics (3 in leadership, 3 in team); the tracked headcount is 26.
| Name | Role | Group |
|---|---|---|
| Director | Leadership | |
| Managing Director | Leadership | |
Sanjith Yeruva | Head - Quality Assurance | Leadership |
Omprakash Hr Manager | Human Resources Manager | Team |
Lini Mathew | Research And Development Manager | Team |
Ahmed Mohammed | Sales Marketing Manager | Team |
Complete people profiles for Elmed Probiotics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Elmed Probiotics
Figures of Elmed Life Sciences Private Limited, the primary company behind Elmed Probiotics, for FY 2025. Revenue was ₹16.97 Cr (+48% year on year). Net profit was ₹2.08 Cr (12% margin). EBITDA was ₹4.00 Cr (24% margin). Revenue has grown at a compounded annual rate of +61% over three years and +252% over five years.
- ₹16.97 CrRevenue · FY 2025 · +48% YoY
- ₹2.08 CrNet profit · 12% margin
- ₹4.00 CrEBITDA · 24% margin
- ₹2.20 CrPaid-up capital
- 26Employees (provident fund records)
- +61%Revenue CAGR, 3 years
- +252%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elmed Life Sciences Private Limited are on its company page.
Detailed financial statements for Elmed Probiotics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Elmed Probiotics
The website of Elmed Probiotics (elmedprobiotics.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 76.4% vs previous month
Similar companies to Elmed Probiotics
10 companies that operate in the same segment as Elmed Probiotics (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elmed Probiotics
Elmed Probiotics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Elmed Probiotics is a funded company, having raised a total of $2.7M across 1 funding round to date. The company's 1st funding round was a Seed of $2.7M, raised on Mar 2026.
Elmed Probiotics has 26 employees.
The primary company behind Elmed Probiotics, Elmed Life Sciences Private Limited, reported revenue of ₹16.97 Cr for FY 2025, up 48% year on year.
ELMED is recognized as a manufacturer of probiotics that are offered for human, animal, and plant health, with a focus on well-documented strains for gut, skin, and soil applications. Segments served include human health through capsules and syrups, animal health for poultry and cattle, aquaculture for vibrio control, and agriculture for ammonia reduction. Various dosage forms such as vials, sachets, and drops are utilized, while facilities are situated in Hyderabad, India. The companys philosophy emphasizes that the quality of life is prioritized, ensuring effective and lasting solutions are delivered across these areas.
Elmed Probiotics offers Probiotics for Human Health and Probiotics for Animal and Agriculture Health.
Elmed Probiotics has 1 investor. Key investors include NABVENTURES.
Elmed Probiotics operates through Elmed Life Sciences Private Limited.
The legal entities of Elmed Probiotics currently have 2 directors, including Pruthivin Reddy Madduri, Nikhil Konkathi.